These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1177 related items for PubMed ID: 29132392
1. False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma. Paek SH, Kim BS, Kang KH, Kim HS. World J Surg Oncol; 2017 Nov 13; 15(1):202. PubMed ID: 29132392 [Abstract] [Full Text] [Related]
2. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area. Lee ST, Kim SW, Ki CS, Jang JH, Shin JH, Oh YL, Kim JW, Chung JH. J Clin Endocrinol Metab; 2012 Jul 13; 97(7):2299-306. PubMed ID: 22500044 [Abstract] [Full Text] [Related]
3. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for diagnosis of thyroid nodules: The influence of false-positive and false-negative results. Zhao CK, Zheng JY, Sun LP, Xu RY, Wei Q, Xu HX. Cancer Med; 2019 Sep 13; 8(12):5577-5589. PubMed ID: 31397092 [Abstract] [Full Text] [Related]
5. Effect of BRAF V600E mutation detection of fine-needle aspiration biopsy on diagnosis and treatment guidance of papillary thyroid carcinoma. Qi W, Shi C, Zhang P, Feng L, Wang J, Chen D. Pathol Res Pract; 2020 Aug 13; 216(8):153037. PubMed ID: 32703500 [Abstract] [Full Text] [Related]
6. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma". Jara SM, Bhatnagar R, Guan H, Gocke CD, Ali SZ, Tufano RP. Head Neck; 2015 Dec 13; 37(12):1788-93. PubMed ID: 24989827 [Abstract] [Full Text] [Related]
7. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis. Marchetti I, Iervasi G, Mazzanti CM, Lessi F, Tomei S, Naccarato AG, Aretini P, Alberti B, Di Coscio G, Bevilacqua G. Thyroid; 2012 Mar 13; 22(3):292-8. PubMed ID: 22181337 [Abstract] [Full Text] [Related]
8. Detection of BRAFV600E mutation on fine needle aspiration specimens of thyroid nodule refines cyto-pathology diagnosis, especially in BRAF600E mutation-prevalent area. Chung KW, Yang SK, Lee GK, Kim EY, Kwon S, Lee SH, Park DJ, Lee HS, Cho BY, Lee ES, Kim SW. Clin Endocrinol (Oxf); 2006 Nov 13; 65(5):660-6. PubMed ID: 17054470 [Abstract] [Full Text] [Related]
9. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma. Zhao H, Zhang ZH, Zhou B, Xiao T, Pan QJ, Guo HQ. Diagn Cytopathol; 2015 Oct 13; 43(10):786-90. PubMed ID: 26152656 [Abstract] [Full Text] [Related]
10. The Combined Use of Fine-Needle Aspiration (FNA) and BRAF V600E Gene Testing: Can it Increase the Definitive Diagnosis Rate of Nodules Categorized as Bethesda III for Papillary Thyroid Carcinoma? Lei L, Hong Qing S, Wei L, Ma Mo Yang F, Xiao Xiang Y. Am Surg; 2024 Dec 13; 90(12):3209-3215. PubMed ID: 39047144 [Abstract] [Full Text] [Related]
12. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAFV600E , and ultrasound elastography. Wang X, Xu F, Gao J, Agyekum EA, Sun H, Zhang G, Li X, Xiang H, Hu S, Qian X. J Clin Ultrasound; 2022 Sep 13; 50(7):942-950. PubMed ID: 35779272 [Abstract] [Full Text] [Related]
13. Increased diagnostic sensitivity of palpation-guided thyroid nodule fine-needle aspiration cytology by BRAF V600E-mutation analysis. Gimm O, Ivansson K, Beka E, Rossitti HM, Garvin S, Söderkvist P. J Pathol Clin Res; 2021 Nov 13; 7(6):556-564. PubMed ID: 34156770 [Abstract] [Full Text] [Related]
14. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology. Johnson SJ, Hardy SA, Roberts C, Bourn D, Mallick U, Perros P. Cytopathology; 2014 Jun 13; 25(3):146-54. PubMed ID: 24417615 [Abstract] [Full Text] [Related]
15. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance. Adeniran AJ, Hui P, Chhieng DC, Prasad ML, Schofield K, Theoharis C. Acta Cytol; 2011 Jun 13; 55(6):570-5. PubMed ID: 22156468 [Abstract] [Full Text] [Related]
16. BRAF mutation analysis and sonography as adjuncts to fine-needle aspiration cytology of papillary thyroid carcinoma: their relationships and roles. Moon WJ, Choi N, Choi JW, Kim SK, Hwang TS. AJR Am J Roentgenol; 2012 Mar 13; 198(3):668-74. PubMed ID: 22358007 [Abstract] [Full Text] [Related]
17. Value of immunohistochemistry in the detection of BRAF(V600E) mutations in fine-needle aspiration biopsies of papillary thyroid carcinoma. Zimmermann AK, Camenisch U, Rechsteiner MP, Bode-Lesniewska B, Rössle M. Cancer Cytopathol; 2014 Jan 13; 122(1):48-58. PubMed ID: 24039206 [Abstract] [Full Text] [Related]
18. Surgical perspective of T1799A BRAF mutation diagnostic value in papillary thyroid carcinoma. Brahma B, Yulian ED, Ramli M, Setianingsih I, Gautama W, Brahma P, Sastroasmoro S, Harimurti K. Asian Pac J Cancer Prev; 2013 Jan 13; 14(1):31-7. PubMed ID: 23534744 [Abstract] [Full Text] [Related]
19. Diagnostic value of FNAC combined with BRAFV600E mutation detection in Hashimoto's thyroiditis complicated with papillary thyroid carcinoma. Fu J, Yin X, Wang X, Xiao S, Wu X, Duan C, Yu W, Zhang G. Front Endocrinol (Lausanne); 2024 Jan 13; 15():1366724. PubMed ID: 38818506 [Abstract] [Full Text] [Related]
20. Prediction Table and Nomogram as Tools for Diagnosis of Papillary Thyroid Carcinoma: Combined Analysis of Ultrasonography, Fine-Needle Aspiration Biopsy, and BRAF V600E Mutation. Kim SK, Lee JH, Woo JW, Park I, Choe JH, Kim JH, Kim JS. Medicine (Baltimore); 2015 May 13; 94(21):e760. PubMed ID: 26020381 [Abstract] [Full Text] [Related] Page: [Next] [New Search]